The global antiarrhythmic drugs market size is anticipated to reach USD 1.62 billion by 2030, growing at a CAGR of 6.4% from 2024 to 2030, according to a report by Grand View Research, Inc. This anticipated growth is driven by multiple interrelated factors, including the rising prevalence of cardiovascular diseases (CVDs), an aging global population, advancements in drug development,...